Ifrah Financial Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Ifrah Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $276,935 - $352,020	-579 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $6,537 - $7,898	-12 Reduced 2.03%	579 $324,000
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $6,413 - $8,370	-13 Reduced 2.15%	591 $368,000
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $203,052 - $298,635	604 New	604 $295,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Ifrah Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Ifrah Financial Services, Inc. with notifications on news.